Total medical devices industry venture financing deals in April 2020 worth $898.52m were announced globally, according to GlobalData’s deals database.
Go deeper with GlobalData
- Embed this chart
Embed this chart into your website
Copy and paste the code below into your website to display the chart.
The value marked an increase of 0.2% over the previous month and a drop of 7.1% when compared with the last 12-month average, which stood at $967.19m.
Comparing deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $418.2m. At the country level, the US topped the list in terms of deal value at $418.2m.
In terms of volumes, North America emerged as the top region for medical devices industry venture financing deals globally, followed by Asia-Pacific and then Europe.
The top country in terms of venture financing deals activity in April 2020 was the US with 47 deals, followed by China with 26 and the UK with five.
In 2020, as of the end of April 2020, medical devices venture financing deals worth $3.93bn were announced globally, marking an increase of 25.1% year on year.
Medical devices industry venture financing deals in April 2020: Top deals
The top five medical devices industry venture financing deals accounted for 34.5% of the overall value during April 2020.
The combined value of the top five medical devices venture financing deals stood at $309.98m, against the overall value of $898.52m recorded for the month.
The top five medical devices industry deals of April 2020 tracked by GlobalData were:
1) BANK OF CHINA INVESTMENT MANAGEMENT, Chongqing Science and Technology Venture Capital, Guangdong Zhutou Innovation, Langmafeng Venture Capital, Qianhai Mother Fund, Telford Capital and Yoyin Medical Fund’s $84.98m venture financing of Guangzhou Huayin Health Technology
2) The $70m venture financing of Click Diagnostics by Cedars-Sinai Medical Center, John Doerr and Pitango Venture Capital
3) LeapFrog Investments, Sequoia Capital China and Sofina’s $55m venture financing of MedGenome Labs
4) The $50m venture financing of TytoCare by Insight Partners, Olive Tree Ventures and Qualcomm Ventures
5) Euclidean Capital, Frazier Healthcare Partners and Longitude Capital Management Co’s venture financing of Dascena for $50m.
Verdict deals analysis methodology
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.
GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.
More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.
